Skip to main navigation Skip to search Skip to main content

Biomaterials as Antigen Delivery Carrier for Cancer Immunotherapy

  • Sungkyunkwan University

Research output: Contribution to journal › Review article › peer-review

Abstract

Since immunotherapy provides an opportunity to treat metastatic and disseminated tumors, it has become a major treatment strategy for cancer. However, current cancer immunotherapeutics have often exhibited insufficient practical outcomes, primarily attributed to inefficient delivery of tumor-associated antigens to elicit anticancer immunity. To achieve improved therapeutic efficacy, numerous efforts have been made to harness biomaterials for the targeted or sustained delivery of tumor-associated antigens to antigen-presenting cells. In this review, we highlight recent advances in the development of biomaterials to deliver tumor-associated antigens and their therapeutic potential for cancer treatment.[Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)834-842
Number of pages9
JournalMacromolecular Research
Volume29
Issue number12
DOIs
StatePublished - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • antigen delivery
  • biomaterials
  • cancer immunotherapy

Fingerprint

Dive into the research topics of 'Biomaterials as Antigen Delivery Carrier for Cancer Immunotherapy'. Together they form a unique fingerprint.

Cite this